Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 06, 2020

SELL
$27.76 - $33.42 $424,450 - $510,991
-15,290 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$20.69 - $37.79 $4,344 - $7,935
210 Added 1.39%
15,290 $457,000
Q4 2019

Feb 03, 2020

BUY
$32.75 - $41.43 $9,825 - $12,429
300 Added 2.03%
15,080 $519,000
Q3 2019

Oct 29, 2019

BUY
$33.73 - $46.27 $498,529 - $683,870
14,780 New
14,780 $499,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.05B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Municipal Employees' Retirement System Of Michigan Portfolio

Follow Municipal Employees' Retirement System Of Michigan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Municipal Employees' Retirement System Of Michigan, based on Form 13F filings with the SEC.

News

Stay updated on Municipal Employees' Retirement System Of Michigan with notifications on news.